Treatment of Verruca Plana by external application of tubeimoside injection: a randomized, double-blind, placebo-controlled, multicenter clinical trial.
- Conditions
- Flat Wart
- Registration Number
- ITMCTR2000003368
- Lead Sponsor
- Shaanxi Provincial Hospital of Traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
1. Patients who meet the diagnostic criteria of Western medicine for verruca plana;
2. Patients aged 18-65 years;
3. Patients with skin lesions on trunk and limbs;
4. Patients who have not used the internal medicine related to this disease, such as vitamin A acid and interferon, have not used the external medicine related to this disease within 30 days before treatment;
5. For the patients without contraindications in this study;
6. Patients signing informed consent.
1. The patients whose skin rash has obviously fused into pieces;
2. Pregnant and lactating women;
3. Patients with scar constitution and allergic constitution;
4. Patients with serious primary diseases such as heart, brain, liver, kidney, hematopoietic system, endocrine system, etc., in which alt, AST > 1.5 times of the upper limit of normal value, Cr, bun > 1.2 times of the normal value;
5. Patients with neurological and mental disorders who are unable to cooperate, and those who suspect or have a history of alcohol and drug abuse;
6. Patients with HIV infection, tumor and low immunity;
7. Patients with interruption during treatment;
8. Patients who participated in other clinical trials in the past month.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Curative Effect of disease;
- Secondary Outcome Measures
Name Time Method Quality of life scale for dermatosis;